Christine Winoto, Director, Rosenman Institute; Founding Partner, MedTech Venture Partners
Christine Winoto is Director of the Rosenman Institute, Deputy Director of QB3, and Founding Partner at MedTech Venture Partners I, LLP. Christine manages the Rosenman Institute, Biotech/Biopharma Pitch Summits, corporate partnership, and QB3 operations. She is also host of the Health Technology podcast. Before joining QB3, she managed business strategy and capital planning for Kaiser Permanente both on the hospital and health plan sides, and managed business development at Genencor. In addition to consulting for startups and venture capital, she has also held R&D and operations positions in medical device companies including Physiometrix (IPO, then acquired by Hospira), Cardiovasc and Heartport. Christine also worked in mergers and acquisitions at the London office of the Dutch investment bank ABN AMRO. Christine holds an MBA from Erasmus University in the Netherlands.